Aging and inflammation limit the induction of SARS-CoV-2-specific CD8+ T cell responses in severe COVID-19.
Saved in:
| Title: | Aging and inflammation limit the induction of SARS-CoV-2-specific CD8+ T cell responses in severe COVID-19. |
|---|---|
| Authors: | Autaa G; University of Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, 33000 Bordeaux, France., Papagno L; University of Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, 33000 Bordeaux, France., Nogimori T; Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan., Boizard-Moracchini A; CHU Bordeaux, Laboratory of Immunology and Immunogenetics, 33000 Bordeaux, France., Korenkov D; University of Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, 33000 Bordeaux, France., Roy M; CHU Bordeaux, Laboratory of Immunology and Immunogenetics, 33000 Bordeaux, France., Suzuki K; The Research Foundation for Microbial Diseases of Osaka University (BIKEN), Osaka, Japan., Masuta Y; Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan., White E; University of Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, 33000 Bordeaux, France., Llewellyn-Lacey S; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom., Yoshioka Y; The Research Foundation for Microbial Diseases of Osaka University (BIKEN), Osaka, Japan.; Vaccine Creation Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Diseases.; Laboratory of Nano-Design for Innovative Drug Development, Graduate School of Pharmaceutical Sciences, and.; Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan., Nicoli F; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy., Price DA; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.; Systems Immunity Research Institute, Cardiff University School of Medicine, Cardiff, United Kingdom., Dechanet-Merville J; University of Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, 33000 Bordeaux, France., Yamamoto T; Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan., Pellegrin I; University of Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, 33000 Bordeaux, France.; CHU Bordeaux, Laboratory of Immunology and Immunogenetics, 33000 Bordeaux, France., Appay V; University of Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, 33000 Bordeaux, France.; Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan. |
| Source: | JCI insight [JCI Insight] 2025 Jan 23; Vol. 10 (4). Date of Electronic Publication: 2025 Jan 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39847442 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Aging and inflammation limit the induction of SARS-CoV-2-specific CD8+ T cell responses in severe COVID-19. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Autaa+G%22">Autaa G</searchLink>; University of Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, 33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Papagno+L%22">Papagno L</searchLink>; University of Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, 33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Nogimori+T%22">Nogimori T</searchLink>; Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Boizard-Moracchini+A%22">Boizard-Moracchini A</searchLink>; CHU Bordeaux, Laboratory of Immunology and Immunogenetics, 33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Korenkov+D%22">Korenkov D</searchLink>; University of Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, 33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Roy+M%22">Roy M</searchLink>; CHU Bordeaux, Laboratory of Immunology and Immunogenetics, 33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Suzuki+K%22">Suzuki K</searchLink>; The Research Foundation for Microbial Diseases of Osaka University (BIKEN), Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Masuta+Y%22">Masuta Y</searchLink>; Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22White+E%22">White E</searchLink>; University of Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, 33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Llewellyn-Lacey+S%22">Llewellyn-Lacey S</searchLink>; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Yoshioka+Y%22">Yoshioka Y</searchLink>; The Research Foundation for Microbial Diseases of Osaka University (BIKEN), Osaka, Japan.; Vaccine Creation Group, BIKEN Innovative Vaccine Research Alliance Laboratories, Research Institute for Microbial Diseases.; Laboratory of Nano-Design for Innovative Drug Development, Graduate School of Pharmaceutical Sciences, and.; Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Nicoli+F%22">Nicoli F</searchLink>; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy.<br /><searchLink fieldCode="AU" term="%22Price+DA%22">Price DA</searchLink>; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.; Systems Immunity Research Institute, Cardiff University School of Medicine, Cardiff, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dechanet-Merville+J%22">Dechanet-Merville J</searchLink>; University of Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, 33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Yamamoto+T%22">Yamamoto T</searchLink>; Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Pellegrin+I%22">Pellegrin I</searchLink>; University of Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, 33000 Bordeaux, France.; CHU Bordeaux, Laboratory of Immunology and Immunogenetics, 33000 Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Appay+V%22">Appay V</searchLink>; University of Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, 33000 Bordeaux, France.; Laboratory of Precision Immunology, Center for Intractable Diseases and ImmunoGenomics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101676073%22">JCI insight</searchLink> [JCI Insight] 2025 Jan 23; Vol. 10 (4). <i>Date of Electronic Publication: </i>2025 Jan 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101676073 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2379-3708 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223793708%22">23793708 </searchLink><i>NLM ISO Abbreviation: </i>JCI Insight <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39847442 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/jci.insight.180867 Languages: – Code: eng Text: English Titles: – TitleFull: Aging and inflammation limit the induction of SARS-CoV-2-specific CD8+ T cell responses in severe COVID-19. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Autaa G – PersonEntity: Name: NameFull: Papagno L – PersonEntity: Name: NameFull: Nogimori T – PersonEntity: Name: NameFull: Boizard-Moracchini A – PersonEntity: Name: NameFull: Korenkov D – PersonEntity: Name: NameFull: Roy M – PersonEntity: Name: NameFull: Suzuki K – PersonEntity: Name: NameFull: Masuta Y – PersonEntity: Name: NameFull: White E – PersonEntity: Name: NameFull: Llewellyn-Lacey S – PersonEntity: Name: NameFull: Yoshioka Y – PersonEntity: Name: NameFull: Nicoli F – PersonEntity: Name: NameFull: Price DA – PersonEntity: Name: NameFull: Dechanet-Merville J – PersonEntity: Name: NameFull: Yamamoto T – PersonEntity: Name: NameFull: Pellegrin I – PersonEntity: Name: NameFull: Appay V IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 01 Text: 2025 Jan 23 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2379-3708 Numbering: – Type: volume Value: 10 – Type: issue Value: 4 Titles: – TitleFull: JCI insight Type: main |
| ResultId | 1 |